Evidence map›Paper›PMID 31413255›Full record

ArticleNature communications2019

PTPσ inhibitors promote hematopoietic stem cell regeneration.

Yurun Zhang, Martina Roos, Heather Himburg, Christina M Termini, Mamle Quarmyne, Michelle Li, Liman Zhao, Jenny Kan, Tiancheng Fang, Xiao Yan and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Crystal structure of the catalytic domain of human RPTPH.Acta crystallographica. Section F, Structural biology communications · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Type IIa RPTPs and Glycans: Roles in Axon Regeneration and Synaptogenesis.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Article
  19. Rac1, A Potential Target for Tumor Therapy.Frontiers in oncology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Yurun ZhangMolecular Biology Institute, University of California, Los Angeles (UCLA), Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0001-6437-1773
Martina RoosDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Heather HimburgDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Christina M TerminiDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0002-1831-1347
Mamle QuarmyneDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Michelle LiDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Liman ZhaoDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Jenny KanDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Tiancheng FangDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Xiao YanDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Katherine PohlDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Emelyne DiersDepartment of Chemistry and Biochemistry, UCLA, Los Angeles, CA, 90095, USA.
Hyo Jin GimDepartment of Chemistry and Biochemistry, UCLA, Los Angeles, CA, 90095, USA.
Robert DamoiseauxJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, 90095, USA.
Julian WhiteleggeDepartment of Psychiatry and Behavioral Sciences, UCLA, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0003-2763-7733
William McBrideJonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, 90095, USA.
Michael E JungDepartment of Chemistry and Biochemistry, UCLA, Los Angeles, CA, 90095, USA.
John P ChuteDivision of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA, 90095, USA. jchute@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-8841-0527
University of California, Los Angeles · USCalifornia NanoSystems Institute · USUCLA Jonsson Comprehensive Cancer Center

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
UCLA Center for Biological RadioprotectorsU19AI067769 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHUTE, JOHN P, MCBRIDE, WILLIAM H. · 2005 to 2019
$44.6M
UC BRAID Center for Accelerated Innovation COVID-19 diagnostic project developmentU54HL119893 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PALAZZOLO, MICHAEL J · 2013 to 2020
$18.3M
Semaphorin signaling regulates vascular and hematopoietic regenerationR01HL086998 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHUTE, JOHN P · 2008 to 2022
$4.6M
NCI NIH HHS P30 CA016042NHLBI NIH HHS R01 HL086998NHLBI NIH HHS U54 HL119893NIAID NIH HHS U19 AI067769
6 · The paper itself

Abstract

Receptor type protein tyrosine phosphatase-sigma (PTPσ) is primarily expressed by adult neurons and regulates neural regeneration. We recently discovered that PTPσ is also expressed by hematopoietic stem cells (HSCs). Here, we describe small molecule inhibitors of PTPσ that promote HSC regeneration in vivo. Systemic administration of the PTPσ inhibitor, DJ001, or its analog, to irradiated mice promotes HSC regeneration, accelerates hematologic recovery, and improves survival. Similarly, DJ001 administration accelerates hematologic recovery in mice treated with 5-fluorouracil chemotherapy. DJ001 displays high specificity for PTPσ and antagonizes PTPσ via unique non-competitive, allosteric binding. Mechanistically, DJ001 suppresses radiation-induced HSC apoptosis via activation of the RhoGTPase, RAC1, and induction of BCL-X

Indexed as

Allosteric RegulationAnimalsAntimetabolites, AntineoplasticApoptosisbcl-X ProteinEnzyme InhibitorsFluorouracilHematopoietic Stem CellsHumansMicerac1 GTP-Binding ProteinRadiationReceptor-Like Protein Tyrosine Phosphatases, Class 2Regenerationrho GTP-Binding ProteinsAntimetabolites, Antineoplasticbcl-X ProteinEnzyme InhibitorsFluorouracilrac1 GTP-Binding ProteinReceptor-Like Protein Tyrosine Phosphatases, Class 2rho GTP-Binding Proteins

Identifiers

PMID31413255
PMCPMC6694155
OpenAlexW2967276942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.